Skip to main content
OpenTrials
Completed

NCT Number: NCT03470610

Administration of Vaginal and Rectal Progesterone During FET Cycles

Observational study of reproductive outcome after frozen embryo transfer in HRT with vaginal and rectal progesterone.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Fertility Clinic Regional Hospital Skive

Skive, 7800, Denmark

About this study

Cohort of patients treated with autologous blastocyst at the Fertility clinic Skive Regional Hospital in HRT cycle. Estradiol stimulation started on second cycle day and on day 12 - 20 vaginal and rectal progesterone is added. Blastocyst transfer on 6th progesterone treatment day. Serum progesterone and hCG measurement 9 or 11 days after embryo transfer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Frozen embryo transfer cycles in HRT cycles

Exclusion criteria

  • Donor frozen embryo transfer

Treatment and study plan

Progesterone

Drug

6 mg estradiol and vaginal and rectal progesterone

Other names: estradiol

Primary outcomes

  1. ongoing pregnancy

    Time frame: 4 month

    gestational week 12

Secondary outcomes

  1. pregnancy rate

    Time frame: 4 month

    positive hCG

  2. Pregnancy loss

    Time frame: 4 month

    pregnancy loss before week 7

Sponsors and collaborators

Lead sponsor

Thor Haahr

Other

Registry information

Official study title

Administration of Vaginal and Rectal Progesterone During Frozen Embryo Transfer Cycles

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 20, 2018
Registry last updated
Sep 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.